These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7946512)

  • 21. [Antibodies against lysosomal enzymes in neutrophil granulocytes are markers in systemic vasculites].
    Nässberger L
    Lakartidningen; 1991 Mar; 88(13):1187-8. PubMed ID: 1850057
    [No Abstract]   [Full Text] [Related]  

  • 22. Hydralazine-induced constrictive pericarditis.
    Franssen CF; el Gamal MI; Gans RO; Hoorntje SJ
    Neth J Med; 1996 May; 48(5):193-7. PubMed ID: 8710038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis.
    Short AK; Lockwood CM
    QJM; 1995 Nov; 88(11):775-83. PubMed ID: 8542262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydralazine and lupus nephritis.
    Ihle BU; Whitworth JA; Dowling JP; Kincaid-Smith P
    Clin Nephrol; 1984 Nov; 22(5):230-8. PubMed ID: 6240359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Auto-antibodies of the IgD class.
    Kantor GL; Van Herle AJ; Barnett EV
    Clin Exp Immunol; 1970 Jun; 6(6):951-62. PubMed ID: 4920553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review.
    Dobre M; Wish J; Negrea L
    Ren Fail; 2009; 31(8):745-8. PubMed ID: 19814644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model.
    Brouwer E; Huitema MG; Klok PA; de Weerd H; Tervaert JW; Weening JJ; Kallenberg CG
    J Exp Med; 1993 Apr; 177(4):905-14. PubMed ID: 8384653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
    Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
    Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced lupus erythematosus syndrome. Immuno-pathological, electronmicroscopical and serological studies.
    Ullman S; Wiik A; Kobayasi T; Halberg P
    Acta Derm Venereol; 1974; 54(5):387-90. PubMed ID: 4138086
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis.
    Arimura Y; Minoshima S; Kamiya Y; Tanaka U; Nakabayashi K; Kitamoto K; Nagasawa T; Sasaki T; Suzuki K
    Clin Nephrol; 1993 Nov; 40(5):256-64. PubMed ID: 8281714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunodiagnostic aspects of autoantibodies against myeloperoxidase.
    Ulmer M; Rautmann A; Gross WL
    Clin Nephrol; 1992 Apr; 37(4):161-8. PubMed ID: 1316247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal gammopathy associated with crescentic glomerulonephritis and antimyeloperoxidase antibodies.
    Martin JC; Ara JM; Picazo L; Pascual-Salcedo D; Puig JG; Torre-Carballada A; Gil A
    Nephron; 1996; 72(1):79-81. PubMed ID: 8903865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of autoantibodies against neutrophil granulocyte components in juvenile chronic arthritis.
    Nässberger L; Truedsson L; Svantesson H
    Clin Exp Rheumatol; 1991; 9(1):79-83. PubMed ID: 1647282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Hanamura K; Tojo A; Kinugasa S; Asaba K; Onozato ML; Uozaki H; Fukayama M; Fujita T
    Hum Pathol; 2011 May; 42(5):649-58. PubMed ID: 21292302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute immunologic hydralazine reaction. Clinical and serological changes after hydralazine administration to a patient with circulating antinuclear antibodies.
    Alarcón-Segovia D
    Rev Invest Clin; 1972; 24(2):167-74. PubMed ID: 4538312
    [No Abstract]   [Full Text] [Related]  

  • 39. [Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies].
    Namba T; Hatanaka M; Takahashi A; Takeji M; Takahara K; Uzu T; Yamauchi A
    Nihon Jinzo Gakkai Shi; 2008; 50(1):64-8. PubMed ID: 18318246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of human monoclonal antibodies to myeloperoxidase.
    Ehrenstein MR; Leaker B; Isenberg D; Cambridge G
    Immunology; 1992 Dec; 77(4):617-20. PubMed ID: 1337335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.